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Abstract
Background: Type 2 diabetic patients display significantly higher incidence of cardiovascular (CV) events including
stroke compared to non-diabetics. Morning blood pressure surge (MBPS) and blunted systolic night-day (SND) ratio
have been associated with CV events in hypertensive patients. No studies have evaluated MBPS in newly diagnosed
diabetic patients or studied the association with vascular target organ damage at this early time point of the
diabetes disease.
Methods: Ambulatory blood pressure monitoring was performed in 100 patients with newly diagnosed type 2
diabetes and 100 age and sex matched controls. MBPS and SND-ratio were calculated. Markers of early vascular
target organ damage included pulse wave velocity (PWV), white matter lesions (WML) on brain MRI, and urine
albumin/creatinine ratio (UAE).
Results: No significant differences in MBPS were found between diabetic patients and controls. Neither MBPS or
SND-ratio were associated with PWV, UAE or WML in the diabetic group independently of age, gender and 24-h
systolic blood pressure. 40.2 % of diabetic patients and 25.8 % of controls were classified as non-dippers (p = 0.03).
Conclusion: MBPS and SND-ratio are not associated with subclinical markers of vascular target organ damage in
our study sample of newly diagnosed type 2 diabetic patients.
Keywords: Morning blood pressure surge, Systolic night-day ratio, Ambulatory blood pressure monitoring, Type 2
diabetes, Vascular target organ damage
Background
Type 2 diabetic patients exhibit significantly higher car-
diovascular (CV) morbidity and mortality compared
with non-diabetics [1]. Recent research has suggested
the morning blood pressure surge (MBPS) as a new risk
marker in ambulatory blood pressure (BP) monitoring
[2–5]. It has been suggested that an exaggerated MBPS
may be involved in the increased incidence of CV events
occurring in the morning, as BP and CV events display
parallel diurnal variations [4, 5]. Although MBPS is cor-
related to the more established systolic night/day (SND)
ratio, evaluation of MBPS in clinical studies has yielded
conflicting data. Indeed, in previous studies in mainly
hypertensive populations a large MBPS has been associ-
ated to both increased [4, 6–9] and decreased [3, 10, 11]
risk of cerebro- and cardiovascular events.
Only a few studies have examined MBPS as a CV risk
factor in type 2 diabetic patients. Both studies included
diabetic patients with long duration of diabetes and with
hypertension as an isolated risk factor. Eguchi et al. [12]
found no association between MBPS and incident car-
diovascular events in a 54 months follow-up study, while
Hermida et al [13] found that a larger MBPS was associ-
ated with lower cardiovascular risk independently of of-
fice BP, but not independently of systolic night blood
pressure. It remains unknown to what extent MBPS and
SND-ratio are independent risk markers in the early
phase of the diabetes disease.
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The reasons for the contrasting findings are unclear
and a better understanding of the pathophysiological
mechanisms linking MBPS to CV events is needed. It
has been suggested, that MBPS may accelerate vascular
injury eventually leading to CV events [14], however
only few studies have evaluated this. Carotid femoral
pulse wave velocity (PWV), cerebral white matter lesions
(WML) and urinary albumin excretion prognosticate CV
events and are markers of vascular target organ damage
yet their association with MBPS only sparsely
investigated.
Therefore, this study was designed to i) assess MBPS
and SND-ratio in a sample of recently diagnosed dia-
betic patients and sex- and age-matched controls and ii)
to investigate the association between MBPS and SND-
ratio and PWV, urine albumin/creatinine ratio (UAE),
and WML in type 2 diabetes.
Methods
Subjects and definitions
The study sample has been described in detail previously
[15]. 100 patients with type 2 diabetes and 100 control
subjects matched individually for sex and age were in-
cluded in the study. The patients were recruited con-
secutively from the outpatient specialised clinics at
Aarhus University Hospital, Aarhus, Denmark. Inclusion
criteria were (i) age > 18 year, (ii) diagnosis of type 2 dia-
betes according to World Health Organization criteria
[16] and (iii) known duration of diabetes less than five
years. The control subjects were recruited by advertising
in local newspapers, and undiagnosed diabetes was ex-
cluded at baseline by fasting glucose and oral glucose
tolerance testing. Exclusion criteria for both groups were
acute or chronic infectious diseases, end stage renal fail-
ure, pregnancy or lactation, prior or current cancer, and
contraindications to magnetic resonance imaging (MRI).
Clinic blood pressure (BP) was calculated as the average
of three measurements. Time and dosage of antihyper-
tensive treatment was unchanged during the study. Body
mass index was calculated as weight/height2 (kg/m2).
Smoking was defined as current, previous, or never. The
study was approved by the Research Ethics Committee
of Central Region, Denmark and by the Danish Data
Protection Agency. All patients gave their written in-
formed consent to participate.
Ambulatory blood pressure monitoring (ABPM)
BP and heart rate were monitored for 24 h using a non-
invasive, portable device (Spacelabs 90217, Spacelabs
Healthcare, Issaquah, WA) validated according to the
British Hypertension Society protocol [17]. Automatic
BP recordings were programmed to occur at 20 min
interval during day and night. Day/night hours and
time of waking up were based on mini-diaries filled out
by the participants during ABPM. Recordings with more
than three missing hours (maximum of 1 h during night)
were excluded from the analyses (3 participants and
their corresponding matches, i.e. 6 subjects). Measure-
ments were performed during a day with normal activ-
ities at home or at work. Mean awake and sleep levels of
SBP and DBP were calculated. Hypertension was diag-
nosed as 24-h SBP > 130 and/or 24 h diastolic BP
(DBP) > 80 mmHg. Dipping-status was based on the re-
duction in nocturnal blood pressure relative to daytime
values. The participants were classified as non-dippers if
the sleep SBP decrease was < 10 %.
Morning Blood Pressure Surge (MBPS)
The most common definitions of MBPS are the sleep-
trough surge and the pre-waking surge, in this study
MS1 and MS2, respectively. Alternative definitions have
been introduced in the literature [2, 18] in this study
MS3-MS5. MS1 was defined as the morning BP (the
average of the two hours just after waking up) minus the
lowest night-time BP (the average of three readings
centred on the lowest night-time reading). Two missing
values were accepted, but not the first two after waking
up. MS2: Morning BP in the two hours just after waking
up minus the average of the readings in the two hours
just before waking up. Again, two missing values were
accepted, but not the last two before waking up. MS3
was calculated as the first BP after waking up minus the
last BP before waking up. No missing values were ac-
cepted. MS4: Average BP one hour after waking up
minus the average of the whole night BP. One missing
value was accepted after waking up, but not the first
one. No more than one hour missing data accepted dur-
ing the night. MS5: The average of the two hours after
waking up minus the whole-night average.
The clinical perspectives regarding MBPS were dis-
cussed by Li et al. [6]. Using two different definitions for
MBPS (MS1 and MS2), the authors suggest that a sys-
tolic MBPS of <20 mmHg is unlikely to be associated
with an increased risk of cardiovascular events in hyper-
tensive patients after accounting for SND-ratio. To
evaluate this cut-off, we dichotomised MBPS data
(MBPS < 20 mmHg = 0, MBPS ≥ 20 mmHg = 1).
Markers of vascular target organ damage
Brain MRI was performed with an eight-channel SENSE
head coil on a 1,5-T MRI scanner (Achieva, Philips,
Best, Netherlands) to obtain axial T2-flair-weighted
scans with a slice thickness of 5 mm. WMLs were
assessed by a blinded, experienced radiologist on T2-
weighted scans and graded 0–2 using Breteler’s scale
(0–4 punctate WMLs = 0, >4 punctate WMLs but no
confluent lesions = 1, presence of confluent WMLs re-
gardless of number of punctate lesions = 2) PWV was
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performed using an applanation tonometer (Millar,
SPT-301B, Houston, TX) and SphygmoCor equipment
and software, version 8.0 (AtCor Medical, Sydney,
Australia). The transit time was determined by the
intersecting tangent algorithm. The distance between
the two arteries was measured directly on the body
using a tape measure and the PWV calculated as dis-
tance divided by time (m/s). UAE was evaluated by al-
bumin/creatinine ratio in a morning urine sample. MRI
data were not available for four participants because of
claustrophobia. PWV data were not recordable in four
participants because of atrial fibrillation and in three
patients due to obesity.
Statistical analysis
Group differences in continuous variables were assessed
using paired t tests. Assumption of normal distributions
was tested by histograms and Q-Q plots. Skewed data
(HbA1c, total cholesterol, triglycerides and urine albumin-
to-creatinine ratio) were log-transformed prior to analysis
to obtain normal distribution. Categorical data were tested
by Chi2 test. Baseline data are presented as means ± SD or
median (25th percentile; 75th percentile) for skewed data.
Associations between morning surge data/systolic night
day-ratio and UAE and PWV were assessed by Pearson’s
correlation coefficient and by multivariate linear regres-
sion analysis. Association with Breteler score was assessed
with ordinal logistic regression analysis. In all multi-
variate analyses, we adjusted for age and sex, and in
analyses in the pooled sample additionally for the effect
of diabetes (yes/no). Blood pressure levels may con-
found the association between morning surge/systolic
night-day ratio and the three outcomes (PWV, UAE
and WML). Accordingly, the effect of including 24-h
systolic BP in the analyses with age and sex was also
evaluated in supplementary analyses. PWV is also
known to be associated with office mean BP and heart
rate, and the effect of including these parameters to-
gether with age and sex in the analyses with PWV as
outcome was also assessed. A two-tailed P value of less
than 0.05 was considered statistically significant. All
statistical calculations were performed with software
from Stata version 11; StataCorp LP, College Station,
Texas, USA). Not all morning BP surge parameters
could be calculated for all participants due to missing
BP data during the night. Accordingly, we did power
calculations for different potential sample sizes. With
80 participants in each group, a standard deviation of
10 mmHg and a 5 % α-level, we had 97 % power to
detect a difference of 6 mmHg in morning surge
between the groups. With 60 participants in each
group, a standard deviation of 10 mmHg and a 5 %
α-level, we had 90 % power to detect a difference of
6 mmHg.
Results
Clinical and laboratory characteristics are presented in
Table 1 for the 97 participants with data on SND-ratio
and their matched control subjects. Diabetic patients were
overweight, and the proportion taking antihypertensive
and cholesterol-lowering treatment was significantly
higher compared with the control group. Consequently,
the diabetic group had significantly lower office BP and
cholesterol levels than the control group. 24-h, day- and
night-time systolic and diastolic blood pressures were not
significantly different between the two groups. The dia-
betic group was characterized by significantly higher urine
albumin/creatinine ratio (UAE) and PWV. Breteler score
was similar distributed in the two groups.
Systolic BP was used for all 5 MBPS calculations in
the 200 participants. Missing values were due to removal
of the portable recording device < 2 h after waking up
(156 calculations) and insufficient night-measurements
(27 calculations). Accordingly, 817 out of 1000 calcula-
tions were successful. As our inclusion was based on
matching data, only matched data was used for compar-
ing diabetic patients and controls and to this end we ex-
cluded MS-data without a match. Finally, 79 matched
calculations were available for MS3, 68 for MS4 and 63
for MS1, MS2 and MS5.
No significant differences were found for any of the
five definitions of MBPS when comparing the diabetic
group and the control group, Fig. 1a (MS1: 27.5 ± 11.2
vs. 24.6 ± 12.2 mmHg; p = 0.13), (MS2: 16.3 ± 10.3 vs.
14.0 ± 11.4 mmHg; p = 0.20), (MS3: 4.7 13.3 ± vs. 7.8 ±
11.6 mmHg; p = 0.11), (MS4: 16.0 ± 10.4 vs. 13.6 ±
11.2 mmHg; p = 0.21), (MS5: 18.2 ± 9.3 vs. 15.3 ±
10.1 mmHg; p = 0.07). The SND-ratio was significantly
higher in the diabetic group than in the control group,
Fig. 1b (0.88 vs. 0.86; p = 0.02). 39 patients with diabetes
(40.2 %) and 25 of the controls (25.8 %) were classified
as non-dippers, p = 0.03.
Univariate and multivariate regression analyses be-
tween MBPS and the subclinical markers PWV, UAE
and WML are presented in Table 2 for MS1 and MS2.
No independent associations between MBPS indices and
WML, PWV, or lnUAE were found after adjustment for
age and sex. Further adjustment for 24-h SBP and dia-
betes in the analyses with lnUAE, WML and PWV and
for mean arterial pressure and heart rate in the analyses
with PWV in fully adjusted models did not change the
results in the total study group or in the diabetic or con-
trol group. Analysis regarding MS3-MS5 showed similar
results.
Participants with a surge above 20 mmHg in the MBPS
parameters used by Li et al. (MS1 and MS2) did not show
increased PWV, UAE or WML when compared to partic-
ipants with a surge below 20 mmHg. However,
MS5 above 20 mmHg was significantly associated to UAE
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(β = 0.42 ± 0.17; p = 0.02) even when adjusting for age, sex,
diabetes mellitus and 24-h systolic BP (β = 0.37 ± 0.17; p =
0.03). This might be a chance finding rather than an actual
validation of the threshold, as none of the other MS-
calculations showed the same tendency.
As previous studies on MBPS primarily have focused on
hypertensive patients, we divided the two groups into
hypertension/normotension based on ABPM data (nor-
motension: <130/80 mmHg on 24-h ABPM) and repeated
all univariate and multivariate analyses. In pooled data on
Table 1 Patient characteristics
Patients with diabetes Controls P-value
Sex, n (Male/female) 97 (50/47) 97 (50/47) -
Age (years) 58.5 ± 9.9 58.3 ± 9.8 -
Diabetes duration (years) (median, (25th;75 th) 1.8; 0.7; 3.2 - -
Smoking, n (Current/previous/never) 21 / 36 / 39 21 / 32 / 44 0.77
Statin use, n (Yes/no) 74/22 18/79 <0.001
Antihypertensive treatment, n (Yes/no) 60/36 23/74 <0.001
RAAS-inhibitors, n 48 11
Calcium-antagonists, n 14 9
Diuretics, n 39 10
β-blockers, n 9 7
BMI (kg/m2) 30.1 ± 4.8 26.1 ± 4.1 <0.001
HbA1c % 6.5 ± 0.6 5.6 ± 0.3 <0.001
HbA1c mmol/mol 48 ± 17 38 ± 20 <0.001
Total cholesterol (mg/dL) 79.2 ± 14.4 100.8 ± 18.0 <0.001
LDL-cholesterol (mg/dL) 41.4 ± 12.6 59.4 ± 18.0 <0.001
HDL-cholesterol (mg/dL) 25.2 ± 5.4 30.6 ± 10.8 <0.001
Triglycerides (mg/dL) (Median, 25th and 75th) 25.2; 19.8; 34.2 21.6; 16.2; 28.8 <0.01
Office measurements (mmHg)
Systolic BP 125.6 ± 11.9 132.2 ± 15.7 <0.05
Diastolic BP 78.8 ± 7.9 84.0 ± 10.5 <0.01
Heart rate 65.9 ± 9.6 62.2 ± 10.7 <0.05
24-h ABPM (mmHg)
Systolic BP 125.3 ± 10.8 124.2 ± 12.4 0.49
Diastolic BP 74.0 ± 7.5 75.3 ± 7.4 0.21
Heart rate 73.3 ± 9.5 68.3 ± 8.9 <0.001
Daytime ABPM (mmHg)
Systolic BP 130.6 ± 11.1 130.5 ± 13.3 0.97
Diastolic BP 78.2 ± 8.0 79.9 ± 8.2 0.12
Heart rate 76.7 ± 10.1 71.8 ± 9.8 <0.01
Nighttime ABPM (mmHg)
Systolic BP 114.9 ± 11.7 112.0 ± 12.0 0.08
Diastolic BP 65.8 ± 7.7 66.3 ± 7.4 0.62
Heart rate 66.6 ± 9.7 61.5 ± 8.8 <0.001
Pulse wave velocity (m/s) 9.3 ± 2.0 8.0 ± 1.6 <0.001
Urine albumine/creatinine (mg/mmol)
(Median, (25th;75 th)) 0.31 (0.21; 0.67) 0.23 (0.15; 0.40) <0.01
Breteler score, n (0/1/2) 52 / 32 / 10 51 / 32 / 13 0.83
Data are presented as n, mean ± SD, or median (interquartile range)
Abbreviations: BMI Body Mass Index, LDL Low Density Lipoprotein, HDL High Density Lipoprotein, BP Blood Pressure, ABPM Ambulatory Blood Pressure Monitoring
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all normotensive participants (n = 91) MS1 was signifi-
cantly associated with lnUAE in univariate and multivari-
ate analyses including age, gender, 24-h SBP and diabetes
(β = 0.02, p = 0.01 and β = 0.02, p = 0.04, respectively). No
association was seen when normotensive diabetic patients
were evaluated separately. MS1 was significantly associ-
ated with lnUAE in normotensive control subjects (n = 47)
in both univariate and multivariate analyses including age,
gender and 24-h SBP (β = 0.02, p = 0.01 and β = 0.02,
p = 0.02, respectively) as were MS4 and MS5 (MS4;
β = 0.03, p = 0.01, MS5; β = 0.03, p = 0.02 and MS4;
β = 0.03, p = 0.01, MS5; β = 0.02, p = 0.03, respectively). No
association was found to WML or PWV for normotensive
participants. MS4 was significantly associated with PWV
in a small (n = 24) subgroup of isolated hypertensive con-
trols even with adjustments for age, sex, 24-h SBP and
mean arterial pressure and heart rate at time of measuring
(p = 0.01) (data not shown).
Finally, as antihypertensive treatment (AHT) could be
hypothesized to affect the MBPS we divided the groups
according to AHT (yes/no). No statistically significant
associations between MBPS measurements and PWV,
WML or lnUAE in either treated or untreated patients
were found after multivariate adjustments including age,
gender, diabetes, and 24-h SBP (data not shown).
The same statistical analyses were completed for associa-
tions between SND-ratio and PWV, lnUAE, and WML, see
Table 3. No independent associations between SND-ratio
and WML, PWV, or lnUAE were found after adjustment
for age and sex. In the normotensive group (n = 109), SND-
ratio was significantly associated with PWV in unadjusted
and adjusted models (β = 8.04 ± 2.79, p = 0.01 and β = 6.31
± 2.48, p = 0.01, respectively). The association remained in a
fully adjusted model with further adjustment for mean
arterial pressure and heart rate (β = 5.40 ± 2.27, p = 0.02).
When evaluated separately, the association was significant
in normotensive diabetics (n = 55) in univariate analysis
(β = 10.27 ± 4.53, p = 0.03), but lost in a fully adjusted
model. In the normotensive controls (n = 54), an associ-
ation was seen only in the fully adjusted model (β = 5.43 ±
2.69, p = 0.049). All groups in AHT were associated with
PWV in univariate analyses, but associations were lost
when adjusting for age and gender (data not shown). No
relation was found to either lnUAE or WML (Table 3).
Discussion
In this study we assessed MBPS in recently diagnosed
type 2 diabetic patients compared with a gender- and
age-matched control group, and studied the association







































Fig. 1 Panel a: Morning blood pressure surge, MS1-MS5 in patients with diabetes (black columns) and controls (white columns) matched for age
and gender. Mean ± SD. MS1: Average of 2 h after waking minus average of lowest night-hour. MS2: Average of 2 h after waking minus average
of 2 h before waking. MS3: First BP after waking minus last BP before waking. MS4: Average of 1 h after waking minus average night BP. MS5:
Average 2 h after waking minus average night. (MS1: 27.5 vs. 24.6 mmHg; p = 0.13), (MS2: 16.3 vs. 14.0 mmHg; p = 0.20), (MS3: 4.7 vs. 7.8 mmHg;
p = 0.11), (MS4: 16.0 vs. 13.6 mmHg; p = 0.21), (MS5: 18.2 vs. 15.3 mmHg; p = 0.07). Panel b: Systolic night/day-ratio in patients with diabetes (black
column) and controls (white column)
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organ damage. The MBPS indices were of similar magni-
tude in the two groups regardless of methods of calcula-
tion. This is opposed to data presented by Afsar et al. [19]
who found higher MBPS in diabetic patients and also in
contrast with Ayala et al. [20] who reported diabetic pa-
tients had significantly lower MBPS than non-diabetics.
The background for the diverging results are unclear, but
may relate to difference in diabetes duration, age, HbA1c-
level, and number and type of antihypertensive drugs in
the different studies. Furthermore, we found that the
SND-ratio and the prevalence of non-dippers were signifi-
cantly higher in the diabetic patients. This is in line with
Table 2 Beta estimates for univariate and multivariate regression analyses of the association between MBPS and subclinical
cardiovascular risk markers
Morning surge Pulse wave velocity Urinary albumin excretion White matter lesions
m/s / mmHg Ln (mg/mmol) / mmHg OR/mmHg
Mean ± SE Mean ± SE Mean ± SE
All
MS1
Unadjusted 0.016 ± 0.010; p = 0.10 0.018 ± 0.007; p = 0.011 0.007 ± 0.014; p = 0.62
Adjusted −0.002 ± 0.010; p = 0.81 0.014 ± 0.007; p = 0.053 −0.002 ± 0.015; p = 0.90
MS2
Unadjusted 0.006 ± 0.016; p = 0.70 0.006 ± 0.009; p = 0.51 0.005 ± 0.013; p = 0.69
Adjusted −0.006 ± 0.011: p = 0.63 0.005 ± 0.008; p = 0.56 −0.001 ± 0.016; p = 0.93
Patients
MS1
Unadjusted −0.017 ± 0.025; p = 0.51 0.019 ± 0.012; p = 0.11 −0.013 ± 0.022; p = 0.56
Adjusted −0.027 ± 0.020; p = 0.18 0.021 ± 0.012; p = 0.08 −0.033 ± 0.024; p = 0.18
MS2
Unadjusted −0.011 ± 0.027; p = 0.68 −0.002 ± 0.013; p = 0.86 0.003 ± 0.023; p = 0.91
Adjusted −0.020 ± 0.022; p = 0.38 0.002 ± 0.014; p = 0.89 −0.013 ± 0.027; p = 0.64
Controls
MS1
Unadjusted 0.028 ± 0.016; p = 0.08 0.012 ± 0.007; p = 0.08 0.022 ± 0.019; p = 0.26
Adjusted 0.018 ± 0.014; p = 0.20 0.009 ± 0.007; p = 0.17 0.018 ± 0.020; p = 0.36
MS2
Unadjusted 0.007 ± 0.019; p = 0.71 0.007 ± 0.008; p = 0.41 0.008 ± 0.021; p = 0.72
Adjusted 0.006 ± 0.016; p = 0.72 0.008 ± 0.008; p = 0.32 0.004 ± 0.022; p = 0.86
All Multivariate analyses adjusted for age, gender and diabetes, Diabetes/controls Adjusted for age and gender, MS morning surge
Table 3 Unadjusted/adjusted p-values for univariate end multivariate regression analyses of the association between systolic night/
day-ratio and subclinical risk markers
Systolic night-day ratio Pulse wave velocity (m/s) Urinary albumin excretion (Ln (mg/mmol)) White matter lesions (Breteler score)
All (176) 0.049 / 0.23 0.72 / 0.77 0.36 / 0.53
Patients with diabetes 0.08 / 0.13 0.86 / 0.99 0.95 / 0.99
Controls 0.45 / 0.85 0.59 / 0.75 0.29 / 0.46
All, normotensive 0.005 / 0.012 0.48 / 0.96 0.31 / 0.27
DM, normotensive 0.027 / 0.09 0.45 / 0.60 0.75 / 0.85
Controls, normotensive 0.38 / 0.10 0.36 / 0.38 0.13 / 0.24
All, hypertensive 0.45 / 0.40 0.84 / 0.72 0.90 / 0.83
DM, hypertensive 0.89 / 0.68 0.33 / 0.31 0.55 / 0.97
Controls, hypertensive 0.06 / 0.13 0.77 / 0.67 0.62 / 0.56
Adjusted for age and gender (and diabetes in pooled data)
DM Patients with diabetes
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previous studies in diabetic patients [21–23]. Afsar et al.
[23] studied 96 newly diagnosed type 2 diabetic patients
and found a prevalence of 56.3 % non-dippers, which is
higher than in our study. Afsar et al. used fixed time inter-
vals for sleep periods and did not include a control group.
All the included patients had essential hypertension,
which also might influence the result.
Previous studies have reported data suggesting an asso-
ciation between MBPS and perturbed vascular function.
Marfella et al. reported increased MBPS was associated
with markers on carotid plaque instability in hypertensive
patients [24] and Yoda et al. found that increased MBPS
was associated with endothelial dysfunction in Japanese
type 2 diabetic patients with long disease duration [14]. In
our study, none of the five MBPS measurements were in-
dependently associated with PWV, WML or UAE. PWV is
a marker of structural changes in the large vessel indica-
tion deteriorating vessel wall elasticity [25] whereas WML
and UAE are primarily manifestations of changes in small
vessel in the brain and kidneys [26, 27]. The three markers
are previously shown to independently predict future cere-
brovascular events in hypertensive and general popula-
tions [26] and cardiovascular events in diabetic
populations with long duration of diabetes [28–30]. A
blunted SND-ratio has also been identified as an inde-
pendent risk marker of target organ damage and cardio-
vascular disease in patients with long duration of diabetes
[31, 32]. The lack of association between SND-ratio and
WML, PWV and lnUAE in diabetic patients in this study
suggests that SND-ratio might reflect other aspects of car-
diovascular risk than these parameters or that a possible
association have not emerged this early in the time course
of the diabetic disease. Yet, this remains speculative as our
data are cross-sectional and accordingly causality cannot
be inferred. However, our results are in line with the longi-
tudinal study by Eguchi et al. [12] who followed 300 Japa-
nese patients with long duration of diabetes for 54 months
and found no independent ability of MS1 or dipping pat-
ters to predict future cardiovascular events. In the 5.4 year
follow-up study of 607 patients with type 2 diabetes con-
ducted by Hermida et al. [13], increased MBPS was signifi-
cantly associated with lower risk of cardiovascular disease,
but the association was lost when including systolic night
BP in cox-regression models. The complex interplay
between MBPS and SND-ratio seems to be more closely
related in diabetic patients than in hypertensive patients,
as no studies yet have shown an independent association
between MBPS and cardiovascular risk factors in diabetic
patients after adjusting for mean night systolic BP. This
study suggests, that newly diagnosed type 2 diabetic
patients could be added to this conclusion; however
further clarification must await longitudinal data.
Previous studies in non-diabetic hypertensive patients
have found associations between MBPS and cerebro-
and cardiovascular morbidity, especially incidence of
stroke [4–9, 33]. When isolating the hypertensive sub-
groups of the control population we found no associ-
ation between MBPS or SND-ratio and subclinical risk
factors of target organ damage. The only exception was
a significant association between MS4 and PWV (p <
0,01 fully adjusted). As the group consisted of only 24
hypertensive controls, the multivariate analysis is prone
to over-fitting and can at best be interpreted as hypothesis
generating. MS1 was associated with lnUAE in pooled
data on normotensive participants as were MS1, MS4 and
MS5 in the subgroup of normotensive control subjects.
This might indicate a linkage between the morning urine
and the MBPS, but needs further investigation.
The significant association between SND-ratio and
PWV in normotensive participants extends previous re-
ports of hypertensive patients [34] and might indicate
early onset of arterial stiffening in non-dippers even in
the normotensive BP range. However, when evaluated
separately, significance was limited to normotensive con-
trols and only in an adjusted model. Hence, the associ-
ation seems to be sensitive to influence from covariates,
and these aspects should be further evaluated. Jennersjö
et al. [35] studied 663 patients with long duration of type
2 diabetes (34.7 % non-dippers) and found non-dipping
independently associated with increased PWV. Our re-
sults in normotensive diabetic patients tend to go in the
same direction, but are insignificant in multivariate ana-
lyses. Furthermore, our results indicate, that in a normo-
tensive population regardless of diabetes, SND-ratio
might contain more valuable information than MBPS.
Our study has limitation that should be observed when
interpreting the results. Due to the cross sectional study
design we cannot infer causality regarding the association
between MBPS and the three outcomes; PWV, UAE and
WML. Furthermore, the diabetic patients had a relatively
low PWV and UAE, and the range was quite narrow for
both. Thus the chance of finding a signal is reduced and
our results may not be applicable in other populations.
Lastly, the lack of the statistical difference in the sub-
groups might be a consequence of low statistical power.
Conclusion
None of the five definitions of morning blood pressure
surge or the systolic night-day ratio were associated with
early markers of vascular target organ damage in our
study sample of newly diagnosed type 2 diabetes pa-
tients. Even though previous studies have found valuable
information regarding cardiovascular risk in MBPS in
hypertensive patients and SND-ratio in diabetes patients,
this study indicates, that these ambulatory blood pres-
sure measurements are not independently associated
with PWV, UAE, or WML at early time point of the dia-
betic disease.
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